General Information of the Compound
Compound ID
CP0054843
Compound Name
2-(2,3-Dimethyl-phenylamino)-benzoic acid
    Show/Hide
Synonyms
2-((2,3-Dimethylphenyl)amino)benzoic acid
2-(2,3-Dimethylanilino)benzoic acid
2-(2,3-Xylidino)benzoic Acid
2-(2,3-dimethylphenylamino)benzoic acid
2-[(2,3-dimethylphenyl)amino]benzoic acid
AGN-1255
APS Brand of Mefenamic Acid
Ac. mefenamico
Ac. mefenamico [Italian]
Acid, Mefenamic
Acid, Mefenaminic
Acide mefenamique
Acide mefenamique [French]
Acide mefenamique [INN-French]
Acido mefenamico
Acido mefenamico [INN-Spanish]
Acidum mefenamicum
Acidum mefenamicum [INN-Latin]
Antigen Brand of Mefenamic Acid
Apo Mefenamic
Apo-Mefenamic
ApoMefenamic
Apotex Brand of Mefenamic Acid
Ashbourne Brand of Mefenamic Acid
Bafameritin-M
Bafhameritin-M
Bonabol
CL 473
CN 35355
CN-35355
Chemidex Brand of Mefenamic Acid
Clonmel Brand of Mefenamic Acid
Contraflam
Coslan
Dyfenamic (TN)
Dysman
Elan Brand of Mefenamic Acid
F0850-6853
Farmasierra Brand of Mefenamic Acid
First Horizon Brand of Mefenamic Acid
Forte, Ponstan
Godecke Brand of Mefenamic Acid
HL 1
ID8
INF 3355
INF-3355
In-M
Lysalgo
M1782
Mafepain (TN)
Mefac
Mefacit
Mefanamic acid
Mefedolo
Mefenacid;Mefenamate
Mefenamic acid
Mefenamic acid (JP15/USP/INN)
Mefenamic acid [USAN:INN:BAN:JAN]
Mefenaminic Acid
Mefenaminsaeure
Mefenaminsaeure [German]
Mefic
Meftal (TN)
Mephadolor (TN)
Mephenamic acid
Mephenaminic acid
Methenamic acid
Mycasaal
N-(2,3-Dimethylphenyl)anthranilic acid
N-(2,3-Xylyl)-2-aminobenzoic acid
N-(2,3-Xylyl)anthranilic acid
N-2,3-Xylylanthranilic acid
Namphen
Nu Mefenamic
Nu Pharm Brand of Mefenamic Acid
Nu-Mefenamic
Nu-Pharm Brand of Mefenamic Acid
NuMefenamic
PMS Mefenamic Acid
PMS-Mefenamic Acid
Parke Davis Brand of Mefenamic Acid
Parkemed
Parkemed (TN)
Pfizer Brand of Mefenamic Acid
Pharmascience Brand of Mefenamic Acid
Pinalgesic
Pinewood Brand of Mefenamic Acid
Ponalar
Ponalgic
Ponmel
Ponstal (TN)
Ponstan
Ponstan (TN)
Ponstan forte
Ponstel
Ponstel (TN)
Ponstil
Ponstyl
Ponsyl
Pontal
Potarlon (TN)
Rolan
Rowa Brand of Mefenamic Acid
Tamany Bonsan
Tanston
Vialidon
Warner Lambert Brand of Mefenamic Acid
Warner-Lambert Brand of Mefenamic Acid
    Show/Hide
Structure
Formula
C15H15NO2
Molecular Weight
241.29
Canonical SMILES
Cc1cccc(Nc2ccccc2C(O)=O)c1C
    Show/Hide
InChI
InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)
    Show/Hide
InChIKey
HYYBABOKPJLUIN-UHFFFAOYSA-N
CAS
61-68-7
Physicochemical Property
logP
3.74524
Rotatable Bonds
3
Heavy Atom Count
18
Polar Areas
49.33
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 4044
SID: 14847469
ChEMBL ID
CHEMBL686
DrugBank ID
DB00784
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 25929 nM
   TI
   LI
   LO
   TS
Protein ID: PT00901, Prostaglandin G/H synthase 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 602 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 2900 nM
2 IC50 = 104480.0862 nM
Protein ID: PT02149, Transient receptor potential cation channel subfamily A member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000620 WI-38 Homo sapiens (Human)  1
1
EC50 = 61000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Mefenamic acid )
Drug Name Mefenamic acid
Indication
Dysmenorrhea
Approved
Target(s)
Prostaglandin G/H synthase 2 (COX-2)
Inhibitor